Cite
MLA Citation
Eda Tanrikulu Simsek et al.. “Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia.” Journal of clinical pathology, vol. 69, no. 9, 2016, pp. 810–816. http://access.bl.uk/ark:/81055/vdc_100135574190.0x00004a